| Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells C Friesen, I Herr, PH Krammer, KM Debatin Nature medicine 2 (5), 574-577, 1996 | 1284 | 1996 |
| Cellular stress response and apoptosis in cancer therapy I Herr, KM Debatin Blood, The Journal of the American Society of Hematology 98 (9), 2603-2614, 2001 | 1044 | 2001 |
| ATF‐2 is preferentially activated by stress‐activated protein kinases to mediate c‐jun induction in response to genotoxic agents. H Van Dam, D Wilhelm, I Herr, A Steffen, P Herrlich, P Angel The EMBO journal 14 (8), 1798-1811, 1995 | 721 | 1995 |
| Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy A Apel, I Herr, H Schwarz, HP Rodemann, A Mayer Cancer research 68 (5), 1485-1494, 2008 | 641 | 2008 |
| CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons A Martin-Villalba, I Herr, I Jeremias, M Hahne, R Brandt, J Vogel, ... Journal of Neuroscience 19 (10), 3809-3817, 1999 | 614 | 1999 |
| The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells S Fulda, H Sieverts, C Friesen, I Herr, KM Debatin Cancer research 57 (17), 3823-3829, 1997 | 571 | 1997 |
| VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma BM Beckermann, G Kallifatidis, A Groth, D Frommhold, A Apel, J Mattern, ... British journal of cancer 99 (4), 622-631, 2008 | 499 | 2008 |
| Dietary constituents of broccoli and other cruciferous vegetables: implications for prevention and therapy of cancer I Herr, MW Büchler Cancer treatment reviews 36 (5), 377-383, 2010 | 411 | 2010 |
| TRAIL/Apo‐2‐ligand‐induced apoptosis in human T cells I Jeremias, I Herr, T Boehler, KM Debatin European journal of immunology 28 (1), 143-152, 1998 | 411 | 1998 |
| Activation of CD95 (APO‐1/Fas) signaling by ceramide mediates cancer therapy‐induced apoptosis I Herr, D Wilhelm, T Böhler, P Angel, KM Debatin The EMBO journal, 1997 | 364 | 1997 |
| Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling G Kallifatidis, V Rausch, B Baumann, A Apel, BM Beckermann, A Groth, ... Gut 58 (7), 949-963, 2009 | 304 | 2009 |
| Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells I Jeremias, C Kupatt, B Baumann, I Herr, T Wirth, KM Debatin Blood, The Journal of the American Society of Hematology 91 (12), 4624-4631, 1998 | 304 | 1998 |
| Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas I Herr, E Ucur, K Herzer, S Okouoyo, R Ridder, PH Krammer, ... Cancer research 63 (12), 3112-3120, 2003 | 287 | 2003 |
| Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics V Rausch, L Liu, G Kallifatidis, B Baumann, J Mattern, J Gladkich, T Wirth, ... Cancer research 70 (12), 5004-5013, 2010 | 262 | 2010 |
| Cross-resistance of CD95-and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases) M Los, I Herr, C Friesen, S Fulda, K Schulze-Osthoff, KM Debatin Blood, The Journal of the American Society of Hematology 90 (8), 3118-3129, 1997 | 257 | 1997 |
| Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate G Kallifatidis, S Labsch, V Rausch, J Mattern, J Gladkich, G Moldenhauer, ... Molecular Therapy 19 (1), 188-195, 2011 | 255 | 2011 |
| Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma G Moldenhauer, AV Salnikov, S Lüttgau, I Herr, J Anderl, H Faulstich Journal of the National Cancer Institute 104 (8), 622-634, 2012 | 237 | 2012 |
| CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non‐small cell lung cancer patients AV Salnikov, J Gladkich, G Moldenhauer, M Volm, J Mattern, I Herr International journal of cancer 126 (4), 950-958, 2010 | 231 | 2010 |
| Autophagy—A double‐edged sword in oncology A Apel, H Zentgraf, MW Büchler, I Herr International journal of cancer 125 (5), 991-995, 2009 | 215 | 2009 |
| c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents A Kolbus, I Herr, M Schreiber, KM Debatin, EF Wagner, P Angel Molecular and cellular biology, 2000 | 208 | 2000 |
